Dr George J Gibeily, MD | |
10810 Connecticut Avenue, Kensington, MD 20895-2138 | |
(301) 929-7100 | |
(301) 929-7114 |
Full Name | Dr George J Gibeily |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 10810 Connecticut Avenue, Kensington, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629144803 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr George J Gibeily, MD 2101 East Jefferson Street, Ppqa Medicare Compliance Unit 6 West, Rockville, MD 20852-4908 Ph: (301) 816-6660 | Dr George J Gibeily, MD 10810 Connecticut Avenue, Kensington, MD 20895-2138 Ph: (301) 929-7100 |
News Archive
InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax's activities.
During the 1970s and 1980s, researchers and policymakers became increasingly worried about multiple consequences of acidic emissions of sulfur dioxide and nitrogen oxides from the stacks of power stations, and eventually they were controlled. In Europe, there was much concern about the effects on Sweden's many lakes, which were found to be in some cases strikingly acidic.
India's lockdown may have hastened spread of COVID-19 to rural areas as millions of migrant workers, trapped in the big cities, ended up being exposed to the virus — which they carried into their distant villages when finally allowed to return.
GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per share, compared with $6.2 million, or $0.60 per share, for the fourth quarter of 2008. The total net loss for 2009 was $27.9 million, or $2.18 per share, compared to $22.7 million, or $2.31 per share, for 2008.
"Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million doses packaged in 10-dose vials," a Sabin Vaccine Institute press release reports.
› Verified 5 days ago
Dr. Mitchell Neal Ross, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7022 | |
Dr. Amadea R Tette, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Dr. Anuj Prashar, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 215-205-0172 | |
Karen Amy Ospina, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10812 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7140 | |
Cynthia L Long, MD Surgery Medicare: Medicare Enrolled Practice Location: 10104 Hadley Pl, Kensington, MD 20895 Phone: 240-393-9825 | |
Dr. Wudneh Muche Temesgen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 |